TickerFacts.

Macrogenics Inc (MGNX): Cost of Revenue

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$3.35M2019-12-31: $02020-12-31: $02021-12-31: $2.65M2022-12-31: $3.35M2023-12-31: $619.0K2024-12-31: $847.0K2025-12-31: $0$0
2019-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$0-100.0%2026-03-09, From 2025-01-01
2024-12-31$847.0K+36.8%2026-03-09, From 2024-01-01
2023-12-31$619.0K-81.5%2026-03-09, From 2023-01-01
2022-12-31$3.35M+26.4%2025-03-20, From 2022-01-01
2021-12-31$2.65Mn/a2024-03-07, From 2021-01-01
2020-12-31$0n/a2023-03-15, From 2020-01-01
2019-12-31$0n/a2022-02-24, From 2019-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Macrogenics Inc (MGNX)2025-12-31$0-100.0%
Elite Pharmaceuticals Inc (ELTP)2026-03-31$73.85M+68.0%
Heron Therapeutics, Inc. (HRTX)2025-12-31$41.35M+7.0%
Liquidia Corp (LQDA)2024-12-31$5.88M+103.6%
Lifecore Biomedical, Inc. (LFCR)2025-05-25$88.57M+2.5%
Phathom Pharmaceuticals, Inc. (PHAT)2025-12-31$22.60M+183.4%
Cryoport, Inc. (CYRX)2025-12-31$93.12M+6.9%
Lifevantage Corp (LFVN)2026-06-30$40.97M-8.7%
Maravai Lifesciences Holdings, Inc. (MRVI)2025-12-31$151.75M+0.6%

Compare MGNX, ELTP, HRTX, LQDA side by side · Screen every company in Pharmaceutical Preparations ↗